Summary
This prediction ended on 10.03.24 with a price of €9.67. The price of Altimmune has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.02%. HC_Wainwright has a follow-up prediction for Altimmune where he still thinks Altimmune is a Buy. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Altimmune | 3.212% | 3.212% | -34.153% | -25.856% |
| iShares Core DAX® | 2,49 % | -5,94 % | 2,90 % | 45,72 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % | 15,75 % | 73,26 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % | 30,35 % | 48,77 % |
| iShares S&P 500 | 1,35 % | -2,94 % | 10,34 % | 55,80 % |
Comments by HC_Wainwright for this prediction
In the thread Altimmune diskutieren
Altimmune, Inc. (NASDAQ: ALT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Ratings data for ALT provided by MarketBeat
In the thread Trading Altimmune
Die von HC_Wainwright gewählte maximale Laufzeit wurde überschritten